62 results
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
consulting, severance, change in control, termination pay, retention, bonus, commission or other incentive, equity or equity-based, phantom equity … payments, change in control payments, retention bonus or other incentive payments, or other similar payments or obligations under any Benefit Plan
424B3
dx4tew6xgvpe5s4m
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
tu0 f211tazhkzydccj8
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
j59gph5ffz7f1xm
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
2cr0o4gozmihj028
16 Jun 23
Business combination disclosure
5:17pm
425
2fv2fdi ib2ee7njm
16 Jun 23
Business combination disclosure
5:16pm
425
b0beljb2rhmx dd1
16 Jun 23
Business combination disclosure
5:14pm
425
3j6 zyt5f
16 Jun 23
Business combination disclosure
5:14pm
425
mrdrevovuo 5p
16 Jun 23
Business combination disclosure
5:12pm
425
c2zmxzsjoeju7eh16u
16 Jun 23
Business combination disclosure
5:11pm
425
rdxmlzewfgm
16 Jun 23
Business combination disclosure
8:08am
425
58dvm pkqq9iqqbfz3a
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
8i6 g66igkx7u64
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am